Changing America reports:
Researchers have developed a new type of blood test to check for potential COVID-19 immunity. How the test works is explained in a study published this week in Nature Biotechnology.
The test, called dqTACT, requires the mixture of a small blood sample with peptides, essentially a chain of proteins, from the COVID-19 virus. Once the mixture takes place, researchers then check after 24 hours to see if there is a T-cell response.
Researchers believe the test could help better anticipate a person’s risk of getting a breakthrough infection and the frequency to which an immunocompromised person should be vaccinated against the virus.
Read the full article.
New rapid test measures immunity to COVID-19. Researchers explained that the test measures the activation of T cells, which are part of the human immune response to a #COVID infection or vaccination and help fight severe illness or death. https://t.co/G4CHycPLmS
— Ian Weissman, DO (@DrIanWeissman) June 17, 2022